Phase 2 N=484 Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
Tularemia
Primary: Safety: Adverse Event Category Rates for All Vaccinations — 264; 162; 53; 48 Adverse events
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.